Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Rubin

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Shock (Augusta, Ga.)|September 23, 2014
Carbon monoxide protects against hemorrhagic shock and resuscitation-induced microcirculatory injury and tissue injuryIbrahim Nassour, Benjamin Kautza, Mark Rubin, et al.
Journal of Proteome Research|March 12, 2009
Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signaturesRobert L Grubb, Jianghong Deng, Peter A Pinto, et al.
Molecular Systems Biology|August 4, 2011
AlleleSeq: analysis of allele-specific expression and binding in a network frameworkJoel Rozowsky, Alexej Abyzov, Jing Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of advanced non-small-cell lung cancer (ATLAS)Fairooz Kabbinavar, Louis Fehrenbacher, John Hainsworth, et al.
JMIR Mental Health|June 7, 2021
Factors Predicting Trial Engagement, Treatment Satisfaction, and Health-Related Quality of Life During a Web-Based Treatment and Social Networking Trial for Binge Drinking and Depression in Young Adults: Secondary Analysis of a Randomized Controlled TrialSamineh Sanatkar, Milena Heinsch, Peter Andrew Baldwin, et al.
The Journal of Urology|January 25, 2017
Racial Variation in the Utility of Urinary Biomarkers PCA3 and T2ERG in a Large Multicenter StudyPadraic G O'Malley, Daniel P Nguyen, Bashir Al Hussein Al Awamlh, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 9, 2020
Work Group Report: Perspectives in Diagnosis and Management of Exercise-Induced Bronchoconstriction in AthletesJustin Greiwe, Andrew Cooke, Anil Nanda, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 20, 2022
Yield of ASPECTS and Collateral CTA Selection for Mechanical Thrombectomy within 6-24 hours from Symptom Onset in a Hub and Spoke SystemBalaji Krishnaiah, Demi Dawkins, Vincent N Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
ATLAS: randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancerBruce E Johnson, Fairooz Kabbinavar, Louis Fehrenbacher, et al.
Assessment|January 10, 2020
Examining the Dimensionality, Reliability, and Invariance of the Depression, Anxiety, and Stress Scale-21 (DASS-21) Across Eight CountriesCristian Zanon, Rachel E Brenner, Makilim N Baptista, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Shock (Augusta, Ga.)|September 23, 2014
Carbon monoxide protects against hemorrhagic shock and resuscitation-induced microcirculatory injury and tissue injuryIbrahim Nassour, Benjamin Kautza, Mark Rubin, et al.
Journal of Proteome Research|March 12, 2009
Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signaturesRobert L Grubb, Jianghong Deng, Peter A Pinto, et al.
Molecular Systems Biology|August 4, 2011
AlleleSeq: analysis of allele-specific expression and binding in a network frameworkJoel Rozowsky, Alexej Abyzov, Jing Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of advanced non-small-cell lung cancer (ATLAS)Fairooz Kabbinavar, Louis Fehrenbacher, John Hainsworth, et al.
JMIR Mental Health|June 7, 2021
Factors Predicting Trial Engagement, Treatment Satisfaction, and Health-Related Quality of Life During a Web-Based Treatment and Social Networking Trial for Binge Drinking and Depression in Young Adults: Secondary Analysis of a Randomized Controlled TrialSamineh Sanatkar, Milena Heinsch, Peter Andrew Baldwin, et al.
The Journal of Urology|January 25, 2017
Racial Variation in the Utility of Urinary Biomarkers PCA3 and T2ERG in a Large Multicenter StudyPadraic G O'Malley, Daniel P Nguyen, Bashir Al Hussein Al Awamlh, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 9, 2020
Work Group Report: Perspectives in Diagnosis and Management of Exercise-Induced Bronchoconstriction in AthletesJustin Greiwe, Andrew Cooke, Anil Nanda, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 20, 2022
Yield of ASPECTS and Collateral CTA Selection for Mechanical Thrombectomy within 6-24 hours from Symptom Onset in a Hub and Spoke SystemBalaji Krishnaiah, Demi Dawkins, Vincent N Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
ATLAS: randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancerBruce E Johnson, Fairooz Kabbinavar, Louis Fehrenbacher, et al.
Assessment|January 10, 2020
Examining the Dimensionality, Reliability, and Invariance of the Depression, Anxiety, and Stress Scale-21 (DASS-21) Across Eight CountriesCristian Zanon, Rachel E Brenner, Makilim N Baptista, et al.
Pageof 9